Baseline Blood Pressure Effect on the Benefit and Safety of Intra-Arterial Treatment in MR CLEAN (Multicenter Randomized Clinical Trial of Endovascular Treatment of Acute Ischemic Stroke in the Netherlands)

Autor: Maxim J.H.L. Mulder, Saliha Ergezen, Hester F. Lingsma, Olvert A. Berkhemer, Puck S.S. Fransen, Debbie Beumer, Lucie A. van den Berg, Geert Lycklama à Nijeholt, Bart J. Emmer, H. Bart van der Worp, Paul J. Nederkoorn, Yvo B.W.E.M. Roos, Robert J. van Oostenbrugge, Wim H. van Zwam, Charles B.L.M. Majoie, Aad van der Lugt, Diederik W.J. Dippel, Wouter J. Schonewille, Jan Albert Vos, Marieke J.H. Wermer, Marianne A.A. van Walderveen, Julie Staals, Jeannette Hofmeijer, Jacques A. van Oostayen, Jelis Boiten, Patrick A. Brouwer, Sebastiaan F. de Bruijn, Lukas C. van Dijk, L. Jaap Kappelle, Rob H. Lo, Ewoud J. van Dijk, Joost de Vries, Paul L.M. de Kort, Jan S.P. van den Berg, Willem Jan J. van Rooij, Boudewijn A.A.M. van Hasselt, Leo A.M. Aerden, René J. Dallinga, Marieke C. Visser, Joseph C.J. Bot, Patrick C. Vroomen, Omid Eshghi, Tobien H.C.M.L. Schreuder, Roel J.J. Heijboer, Koos Keizer, Alexander V. Tielbeek, Heleen M. den Hertog, Dick G. Gerrits, Renske M. van den Berg-Vos, Giorgos B. Karas, Henk A. Marquering, Ludo F. Beenen, Marieke E.S. Sprengers, Sjoerd F.M. Jenniskens, René van den Berg, Albert J. Yoo, Peter J. Koudstaal, H. Zwenneke Flach, Ewout W. Steyerberg
Přispěvatelé: ACS - Amsterdam Cardiovascular Sciences, Radiology and Nuclear Medicine, ANS - Neurovascular Disorders, Graduate School, Neurology, Biomedical Engineering and Physics, Other Research, ARD - Amsterdam Reproduction and Development, AGEM - Amsterdam Gastroenterology Endocrinology Metabolism, ACS - Microcirculation, ACS - Atherosclerosis & ischemic syndromes, ACS - Pulmonary hypertension & thrombosis, Radiology & Nuclear Medicine, Public Health, MUMC+: MA AIOS Neurologie (9), MUMC+: MA Neurologie (3), RS: CARIM - R3.03 - Cerebral small vessel disease, Klinische Neurowetenschappen, MUMC+: DA BV Medisch Specialisten Radiologie (9), RS: CARIM - R3.11 - Imaging, Beeldvorming
Rok vydání: 2017
Předmět:
Male
endovascular treatment
medicine.medical_treatment
RECANALIZATION
030204 cardiovascular system & hematology
GUIDELINES
THERAPY
Brain Ischemia
EARLY MANAGEMENT
law.invention
0302 clinical medicine
Randomized controlled trial
law
Modified Rankin Scale
Outcome Assessment
Health Care

EPIDEMIOLOGY
Stroke
Netherlands
Endovascular Procedures
blood pressure
ASSOCIATION
Thrombolysis
Middle Aged
Disorders of movement Donders Center for Medical Neuroscience [Radboudumc 3]
thrombectomy
Cardiology
Female
Cardiology and Cardiovascular Medicine
Intracranial Hemorrhages
medicine.medical_specialty
hypertension
TISSUE-PLASMINOGEN-ACTIVATOR
03 medical and health sciences
Internal medicine
Post-hoc analysis
ischemic stroke
medicine
Humans
cardiovascular diseases
Aged
Retrospective Studies
HEALTH-CARE PROFESSIONALS
THROMBOLYSIS
Advanced and Specialized Nursing
business.industry
Other Research Radboud Institute for Health Sciences [Radboudumc 0]
Odds ratio
medicine.disease
Surgery
Clinical trial
Blood pressure
Neurology (clinical)
business
030217 neurology & neurosurgery
Zdroj: Stroke; a journal of cerebral circulation, 48(7), 1869-1876. Lippincott Williams and Wilkins
Stroke, 48(7), 1869-1876
Stroke, 48, 7, pp. 1869-1876
Stroke, 48(7), 1869-1876. Lippincott Williams & Wilkins
Stroke, 48, 1869-1876
Stroke, 48(7), 1869-1876. LIPPINCOTT WILLIAMS & WILKINS
ISSN: 1524-4628
0039-2499
DOI: 10.1161/strokeaha.116.016225
Popis: Background and Purpose— High blood pressure (BP) is associated with poor outcome and the occurrence of symptomatic intracranial hemorrhage in acute ischemic stroke. Whether BP influences the benefit or safety of intra-arterial treatment (IAT) is not known. We aimed to assess the relation of BP with functional outcome, occurrence of symptomatic intracranial hemorrhage and effect of IAT. Methods— This is a post hoc analysis of the MR CLEAN (Multicenter Randomized Clinical Trial of Endovascular Treatment of Acute Ischemic Stroke in the Netherlands). BP was measured at baseline, before IAT or stroke unit admission. We estimated the association of baseline BP with the score on the modified Rankin Scale at 90 days and safety parameters with ordinal and logistic regression analysis. Effect of BP on the effect of IAT was tested with multiplicative interaction terms. Results— Systolic BP (SBP) had the best correlation with functional outcome. This correlation was U-shaped; both low and high baseline SBP were associated with poor functional outcome. Higher SBP was associated with symptomatic intracranial hemorrhage (adjusted odds ratio, 1.25 for every 10 mm Hg higher SBP [95% confidence interval, 1.09–1.44]). Between SBP and IAT, there was no interaction for functional outcome, symptomatic intracranial hemorrhage, or other safety parameters; the absolute benefit of IAT was evident for the whole SBP range. The same was found for diastolic BP. Conclusions— BP does not affect the benefit or safety of IAT in patients with acute ischemic stroke caused by proximal intracranial vessel occlusion. Our data provide no arguments to withhold or delay IAT based on BP. Clinical Trial Registration— URL: http://www.isrctn.com . Unique identifier: ISRCTN10888758.
Databáze: OpenAIRE